GEODE CAPITAL MANAGEMENT, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$56,062,490
+7.5%
483,235
+8.8%
0.01%
+16.7%
Q2 2023$52,156,124
+51.3%
444,260
+3.2%
0.01%
+50.0%
Q1 2023$34,471,514
+105485.4%
430,571
+4.5%
0.00%
-20.0%
Q4 2022$32,648
-99.9%
412,127
+3.2%
0.01%
+25.0%
Q3 2022$27,828,000
+10.0%
399,262
+3.6%
0.00%0.0%
Q2 2022$25,303,000
+4.1%
385,375
+5.5%
0.00%
+33.3%
Q1 2022$24,306,000
+5.3%
365,290
+10.7%
0.00%0.0%
Q4 2021$23,078,000
+39.2%
329,926
+3.9%
0.00%
+50.0%
Q3 2021$16,582,000
-23.8%
317,608
-0.8%
0.00%
-33.3%
Q2 2021$21,771,000
-1.1%
320,176
+12.0%
0.00%0.0%
Q1 2021$22,020,000
+53.7%
285,833
+19.7%
0.00%
+50.0%
Q4 2020$14,322,000
+59.2%
238,707
+14.2%
0.00%0.0%
Q3 2020$8,994,000
+20.4%
208,941
+15.9%
0.00%0.0%
Q2 2020$7,469,000
+3.5%
180,346
+8.1%
0.00%0.0%
Q1 2020$7,216,000
-55.6%
166,895
-43.1%
0.00%0.0%
Q4 2019$16,256,000
+226.5%
293,566
+104.7%
0.00%
+100.0%
Q3 2019$4,979,000
+3.2%
143,396
+19.7%
0.00%0.0%
Q2 2019$4,823,000
+104.5%
119,767
+67.0%
0.00%0.0%
Q1 2019$2,358,000
-6.4%
71,698
-40.8%
0.00%
Q4 2018$2,518,000
+292.8%
121,206
+232.4%
0.00%
Q3 2018$641,000
+18.3%
36,4660.0%0.00%
Q2 2018$542,00036,4660.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders